licensed under a . Your use of this Creative Commons Attribution-NonCommercial-ShareAlike License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License . Your use of this material constitutes acceptance of that license and the conditions of use of materials on this site.

Copyright 2006, The Johns Hopkins University and Duff Gillespie. All rights reserved. Use of these materials permitted only in accordance with license rights granted. Materials provided “AS IS”; no representations or warranties provided. User assumes all responsibility for use, and all liability related thereto, and must independently review all materials for accuracy and efficacy. May contain materials owned by others. User is responsible for obtaining permissions for use from third parties as needed.

Monitoring and Evaluation

IN ACTION!

Duff Gillespie

CASE STUDIES

Monitoring for Problem Identification and

Resolution

Program Evaluation

Selected Issues

GLOBAL EPI

Problem

Testing of vaccine potency found millions of doses that had lost their potency due to cumulative heat exposure

Immunization campaigns being compromised because:

- children receiving worthless vaccines

- questionable vaccines destroyed

- lower coverage rates

- millions dollars wasted

SOLUTION

Vaccine Vial Monitors (VVM) for:

ƒ Oral polio

ƒ Measles

ƒ Hib

ƒ BCG

ƒ Yellow fever

ƒ Hepatitis B

ƒ Diphtheria

ƒ Tetanus

ƒ Pertussis

VVM color coded labels allow for easy identification of vaccines over-exposed to heat

MONITORING CONDOM SHIPMENTS

Problem

Shipments of condoms to Sub-Saharan Africa were declining, despite rise of HIV infections

Declines not counterbalanced by other donors

Significant condom gap

CONDOM GAP IN AFRICA

35.0

30.0

25.0

20.0

15.0

10.0

5.0

0.0

Average Availability of Top 6 Countries = 16.9

Additional Condoms Needed to Get All SSA Countries to the level of 16.9 = 2 billion per year

Countries In Sub-Saharan Africa

Top Six

Horizontal line represents average procurement of top 6 countries - Botswana, South Africa, Zimbabwe,

Togo, Congo and Kenya). Overall provision of condoms is 4.6 per man per year.

AMELIORATIVE ACTIONS

ƒ Creation of Condom Fund

ƒ Formation of Reproductive Health Supplies Coalition

ƒ Demand Creation

ƒ ABC battles make corrective actions difficult

TRACKING IMMUNIZATION

Problem

Stagnation or decline in immunization coverage in

Africa

Problem identified through surveys, well after serious degrading of EPI

Tracking of vaccine shipments or funding levels could have served as early warning system

AMELIORATIVE ACTIONS

ƒ Reallocation of Funds

ƒ UNICEF/USAID Taskforce

ƒ Partnership for Maternal, Newborn and Child Health

ƒ Field Guidance

ƒ Global Alliance for Vaccines and Immunization

(GAVI) and GAVI Funds (Private-Public Partnership)

SYSTEM EVALUATIONS

Problem

Very Poor Access to Family Planning, especially in rural areas

-services offered by medical personnel

-rigid screening

-fixed facilities

Low Contraceptive Prevalence

SOLUTION

Series of quasi-experimental studies

-areas with lay CBD providers vs. standard of care

-conducted in all geographical regions

-over 25 studies

RESULTS

Without exception, dramatic increases in treatment areas with modest or no increase in control areas

IMPACT

Change in policies and programs

CBD is now the norm

Dramatic increase in prevalence

SELECTED M&E ISSUES

SELECTED M&E ISSUES

Monitoring System must be

Timely

Utilized

Accurate

SELECTED M&E ISSUES

Project vs. Impact Evaluation

Project: Did the contractor do what you paid them to do?

Impact: Did you ask them to do the right thing?

SELECTED M&E ISSUES

Program Evaluation from the Get Go

IMCI

Multi-country Evaluation

SELECTED M&E ISSUES

M&E Indicators Frame

Program Inputs and Activities

Contraceptive Prevalence vs. Continuation Rates

SELECTED M&E ISSUES

Many Decisions are Not Evidence Based

ƒ Recent examples:

ƒ FDA EC Decision

ƒ Abstinence

ƒ Condom Degradation

ƒ Needle Exchange Programs

SELECTED M&E ISSUES

Critical Mass of Evidence Often Needed for Fundamental Changes

ƒ CBD Family Planning

ƒ ORT

ƒ Vitamin A Supplementation

SELECTED M&E ISSUES

RESULTS ARE NOT ENOUGH!

The Case of Vitamin A Supplementation

SELECTED M&E ISSUES

Diffusion of Vitamin A

11 field trials

6 meta analyses

g

900

800

700

1987: WHO and

UNICEF recommend VA for treatment of measles

600

500

400

300

200

1975: IVACG established

1975: Sugar fortification in

Central America

1972: Secretary of State,

Kissinger pledges support for

VA to first World Conference on

Food in Rome

1972: U.S. devotes $3 million

VA

1972: 5 countries begin VA supplementation

100

1965: U.S. begins fortifying nonfat dry milk for Food for Peace

Program

0

1984: Congressional

Hunger Committee

1984: Jim Grant

(UNICEF) epiphany

1983: Sommer article in Lancet

1993: World Bank

Development Report highlights higher cost-benefits of VA

1993: Beaton/Fawzi

Meta-analysis

Meetings setting

VA goals

1990: World Summit for Children

1990: UNICEF/WHO

Montreal Conference

1992: International

Conference on

Nutrition

1992: Bellagio

1985: UNICEF focuses on VA

1985: U.S. Congress creates VA funding mandate

1996: CIDA commits to VA capsule procurement

1999: USAID’s

Global VITA

Alliance

1986-1992:

Confirmational Studies

1985-1987: USAID funds research confirming VA saves children’s lives

1998: WHO/

UNICEF endorse integrating VA and EPI/NIDS

2002: Vitamin A supplementation in over 80 countries

19

62

19

64

19

66

19

68

19

70

19

72

19

74

19

76

19

78

19

80

19

82

19

84

19

86

19

88

19

90

19

92

19

94

19

96

19

98

20

00

20

02

Adapted from EM Rogers. Diffusion of Innovations . Free Press, 2005.